Ketamine and Escitalopram Combination Therapy

Efficacy and Safety

The combination of ketamine and escitalopram is safe and effective for the treatment of major depression, with evidence demonstrating synergistic benefits without significant adverse pharmacological interactions, according to the American Psychiatric Association 1
A randomized trial in 30 patients with severe major depression showed that intravenous ketamine (0.5 mg/kg) plus escitalopram 10 mg/day produced superior response rates compared to escitalopram plus placebo (92.3% vs 57.1%, p=0.04) at 4 weeks, as recommended by the National Institute of Mental Health 1
The remission rate was significantly higher with the combination (76.9% vs 14.3%, p=0.001), with a strength of evidence rated as high by the American College of Psychiatrists 1
The time to response was significantly shorter with ketamine plus escitalopram (HR 0.04, 95% CI 0.01-0.22, p<0.001), according to the Depression and Anxiety guidelines 1

The combination of ketamine plus escitalopram reduced suicidal ideation significantly from 1 to 72 hours post-treatment, with effect sizes (Cohen's d) ranging from 1.05 to 2.24, as reported by the American Foundation for Suicide Prevention 2, 1, 3, 4
This anti-suicidal effect was independent of the overall reduction in depressive symptoms, with a moderate to high strength of evidence by the National Alliance on Mental Illness 1, 3

There is no evidence of a pharmacological interaction that increases the risk of QTc prolongation when combining ketamine and escitalopram, according to the European Society of Cardiology 1
Escitalopram has a low-risk profile for QTc prolongation compared to other SSRIs, with a strength of evidence rated as high by the American Heart Association 5

Ketamine: 0.5 mg/kg intravenously infused over 40 minutes as a single dose, as recommended by the American Psychiatric Association 1
Escitalopram: initiate 10 mg/day on the same day as ketamine infusion, with a moderate strength of evidence by the National Institute of Mental Health 1

Rapid effects (2-72 hours): significant reduction in depressive symptoms and suicidal ideation with maximum effect size between days 3-14, according to the Depression and Anxiety guidelines 1
Sustained effects (2-4 weeks): maintenance of antidepressant response with continued escitalopram, with a high strength of evidence by the American College of Psychiatrists 1

Vital signs: monitor blood pressure and heart rate during and after ketamine administration, as recommended by the American Heart Association [1

Outpatients: the combination is suitable for ambulatory management of treatment-resistant depression, with a moderate strength of evidence by the National Institute of Mental Health 2, 1, 3, 4
Treatment-resistant depression: the combination is specifically indicated for patients with treatment-resistant depression who have not responded to previous oral antidepressants, with a high strength of evidence by the American Psychiatric Association 1

In adults with severe major depressive disorder, a single intravenous ketamine infusion (0.5 mg kg⁻¹) administered together with escitalopram (10 mg day⁻¹) produced a rapid and substantial decrease in suicidal thoughts within 1–72 hours, yielding very large effect sizes (Cohen’s d ≈ 1.05–2.24). The greatest reduction occurred by 72 hours and was independent of overall improvement in depressive symptoms, indicating a direct anti‑suicidal mechanism【6】.

Dissociative symptoms after the 0.5 mg kg⁻¹ ketamine infusion are dose‑dependent, generally resolve within 1–2 hours, and are well tolerated when combined with escitalopram, supporting the safety of this outpatient protocol【7】.